Adjuvant bisphosphonate therapy is normally increasingly found in postmenopausal breast cancer individuals. deaths among females worldwide [1]. Developments in treatment for breasts cancer have significantly improved success and clinical final results lately [2]. For endocrine-responsive breasts cancer tumor, endocrine therapy is among the most regular adjuvant treatment after locoregional treatment. Endocrine therapies for breasts cancer… Continue reading Adjuvant bisphosphonate therapy is normally increasingly found in postmenopausal breast cancer